Related Tags >> Amgen Kyowa Hakko Boehringer Ingelheim MedImmune

Nycomed News

Most Popular Nycomed Story

Yasuchika Hasegawa - The 25 most influential people in biopharma today

February 7, 2012 — 4:46pm ET | By Suzanne Elvidge

Revising the portfolio Yasuchika HasegawaCEOTakeda Pharmaceutical Yasuchika Hasegawa, CEO of Takeda Pharmaceutical, is a man with ambition. He has moved the Japanese pharmaceutical company into the Read more...

Nycomed Press Releases

NPS Pharmaceuticals to Host Conference Call to Discuss Data Reported at American College of Gastroenterology Annual Scient
NPS Pharmaceuticals to Report Third Quarter 2011 Financial Results
Micromet to Report Third Quarter 2011 Financial Results on November 8
BIO-Europe® 2011 program to highlight non-traditional partnerships and the year’s transformational deals
Takeda Completes Acquisition and Names New CEO of Nycomed

Latest Headlines

Yasuchika Hasegawa - The 25 most influential people in biopharma today
February 7, 2012
Takeda to ax 2,800 workers, consolidate R&D in global restructuring
January 18, 2012
Takeda wraps $13.7B Nycomed buyout, skin unit spins off
May 19, 2011
Deal or no deal? Takeda scuttles report on imminent $13B pact for Nycomed
May 18, 2011
Takeda: No deal has been struck for Nycomed
May 13, 2011
Takeda pursues Nycomed with $12B-$14B buyout offer
May 12, 2011
Forest, Nycomed win narrow FDA approval on new COPD drug
March 1, 2011
Nycomed US names new CEO
July 19, 2010
Nycomed wins EU approval for COPD therapy
July 6, 2010
FDA stiff-arms Daxas, demands more info on COPD drug
May 18, 2010
Nycomed scores Merck co-promotion pact for Daxas
April 26, 2010
EU recommends Daxas approval following FDA panel rejection
April 23, 2010
FDA panel rejects Forest, Nycomed drug Daxas for COPD
April 8, 2010
FDA staffers question Daxas' safety, benefits and suicides as review looms
April 5, 2010
Bidding heats up for Solvay's drug unit
September 25, 2009
Sources: Abbott sparks Solvay bidding war, UCB may follow
September 24, 2009
Report: Nycomed makes potential $6.6B bid for Solvay unit
September 18, 2009
Promising results for Nycomed, Forest COPD drug Daxas
August 28, 2009
Forest Labs pays $100M upfront in Daxas pact
August 10, 2009
Nycomed, others eye Solvay drug unit
July 15, 2009

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events